Cargando…

Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?

The outbreak of the Coronavirus disease (COVID-19) pandemic has deeply challenged healthcare systems and care of patients with cancer. Phase 1 studies are among the most complicated clinical trials and require thorough patient selection, as well as intensive patient monitoring. In this perspective,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Postel-Vinay, Sophie, Massard, Christophe, Soria, Jean-Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Current Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383132/ https://www.ncbi.nlm.nih.gov/pubmed/32805640 http://dx.doi.org/10.1016/j.ejca.2020.07.009

Ejemplares similares

Patient-reported tolerability of adverse events in phase 1 trials
por: Henon, Clémence, et al.
Publicado: (2017)

A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials
por: Kempf, Emmanuelle, et al.
Publicado: (2016)

Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study
por: Priou, Sonia, et al.
Publicado: (2022)

Deep Brain Stimulation for Addictive Disorders—Where Are We Now?
por: Yuen, Jason, et al.
Publicado: (2022)

Time to progression ratio in cancer patients enrolled in early phase clinical trials: time for new guidelines?
por: Watson, Sarah, et al.
Publicado: (2018)

Six weeks into the 2019 coronavirus disease outbreak: it is time to consider strategies to impede the emergence of new zoonotic infections
por: Harypursat, Vijay, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)
por: Tougeron, David, et al.
Publicado: (2021)

Cancer treatment during the coronavirus disease 2019 pandemic: Do not postpone, do it!
por: Omarini, Claudia, et al.
Publicado: (2020)

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Are we ready to build health systems that consider the climate?
por: Mayhew, Susannah, et al.
Publicado: (2014)

Should COVID-19 Vaccines Authorized for Emergency Use Be Considered “Essential” Medicines?
por: Smith, Maxwell J., et al.
Publicado: (2021)

Can Increased Recovery Rates from Coronavirus be explained by Prevalence of ADHD? An Analysis at the US Statewide Level
por: Arbel, Yuval, et al.
Publicado: (2020)

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
por: Mansi, Laura, et al.
Publicado: (2021)

What Should We Do About Habitual Caffeine Use in Athletes?
por: Pickering, Craig, et al.
Publicado: (2018)

Can the ability to adapt to exercise be considered a talent—and if so, can we test for it?
por: Pickering, Craig, et al.
Publicado: (2017)

Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?
por: Plocque, Alexia, et al.
Publicado: (2022)

How should we be selecting our graduate students?
por: Weiner, Orion D.
Publicado: (2014)

The Middle East Respiratory Syndrome—How Worried Should We Be?
por: Perlman, Stanley
Publicado: (2013)

POHaD: why we should study future fathers
por: Soubry, Adelheid
Publicado: (2018)

Whipple Grossing in the Era of New Staging: Should We Standardize?
por: Shi, Jiaqi, et al.
Publicado: (2019)

How should we interpret conclusions of TKI-stopping studies
por: Gale, Robert Peter, et al.
Publicado: (2023)

Do Non-Responders to Exercise Exist—and If So, What Should We Do About Them?
por: Pickering, Craig, et al.
Publicado: (2018)

Radiology practice in sub-Saharan Africa during the COVID-19 outbreak: points to consider
por: Mutala, Timothy Musila, et al.
Publicado: (2020)

Prisoners in a pandemic: We should think about detainees during Covid-19 outbreak
por: Tozzo, Pamela, et al.
Publicado: (2020)

Health insurance system for hematologic diseases: what should we do?
por: Jang, Moon Ju, et al.
Publicado: (2011)

We should abandon the Brighton Collaboration criteria for vaccine-associated anaphylaxis
por: Hurley, Sadhbh, et al.
Publicado: (2022)

Nomograms Should Not Be Used by General Neurologists When Considering Referral for Epilepsy Surgery
por: King-Stephens, David
Publicado: (2022)

Mini-Review: Role of Drugs Affecting Renin-Angiotensin System (RAS) in Traumatic Brain Injury (TBI): What We Know and What We Should Know
por: Sarpolaki, Mohammad Kazem, et al.
Publicado: (2023)

Should Heartbeats/Training Session Be Considered When Comparing the Cardiovascular Benefits of High-Intensity Interval Aerobic and Moderate-Intensity Continuous Training? A Critical Appraisal
por: Rodrigues, Jhennyfer Aline Lima, et al.
Publicado: (2020)

Multiple sclerosis: why we should focus on both sides of the (auto) antibody
por: den Dunnen, Jeroen, et al.
Publicado: (2021)

Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies
por: Qi, Luo, et al.
Publicado: (2022)

Should we predict poor prognosis in autotransplantation of teeth with completed root formation?
por: Al-Khanati, Nuraldeen Maher, et al.
Publicado: (2022)

National Institutes of Health Blueprint Neurotherapeutics Network: Results to Date and Path Forward
por: Cywin, Charles L., et al.
Publicado: (2017)

Erythema nodosum: what should we consider about it?
por: Babamahmoudi, Farhang, et al.
Publicado: (2016)

NephroCheck: should we consider urine osmolality?
por: Noto, Alberto, et al.
Publicado: (2019)

The golden era of videolaryngoscopy: costs we should consider
por: Choi, Geun Joo
Publicado: (2022)

Editorial: The Future of Environmental Medicine in Environmental Health Perspectives: Where Should We Be Headed?
por: Schwartz, Brian S., et al.
Publicado: (2005)

Perspective: Total, Added, or Free? What Kind of Sugars Should We Be Talking About?
por: Mela, David J, et al.
Publicado: (2018)

COVID-19 and Lessons to Be Learned from Prior Coronavirus Outbreaks
por: Deming, Meagan E., et al.
Publicado: (2020)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2fmc1vgs2bm58igqsgpft4pqr2